Log InCreate an Account
  • Home
  • Contact us
  • SCAI.org Home |
  • SecondsCount.org |
  • eLearning Library |
  • Contribute to SCAI PAC |
  • my.scai.org
  • My SCAI
  • My Community
  • Member Directory
 Menu
  • Overview
  • Case Studies
  • Sorry! To unlock all site features, we'll need to collect some information from you.
  • Unit 8.5b: Stent Thrombosis: Incidence, Timing, Outcome, Optimizing Pharmacology

    Martin B. Leon, MD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour


    Faculty Disclosure

    Nothing to Disclose


    Learning Objectives

    • Describe sirolimus-eluting stent (SES) components and drug actions
    • Explain the angiographic and clinical results of randomized trials comparing SES and bare metal stents (BMS)
    • Review the effects of SES in complex lesion subsets
    • Discuss the frequency of early and late stent thrombosis after SES implantation
* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:
* Message:
 

Thank you

Your feedback has been sent.